Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

(Mis)Treatment of Acute Herpes Zoster

(Mis)Treatment of Acute Herpes Zoster Abstract Recent attention has been focused on new antiviral agents for the treatment of herpes zoster both in the medical literature1 and in the lay press (Wall Street Journal. July 12, 1933;B1, 5). Since acyclovir was approved for treatment of herpes zoster in April 1990, we have kept a log at the University of Texas Medical Branch, Galveston, of patients presenting at our clinics who inform us that they were previously treated for shingles by their local physician. Interestingly, only 33 (17%) of 197 of these patients had received acyclovir at the recommended dosage of 800 mg orally five times per day for 7 to 10 days. Another 56% of the patients reported being treated with acyclovir at lower oral dosages and/or with topical acyclovir. The remaining 27% of patients were treated with oral antibacterial agents and/or a variety of other non-antiviral drugs. As we actively enroll patients in clinical References 1. Straus SE. Shingles: sorrows, salves, and solutions . JAMA . 1993;269:1836-1839.Crossref http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Internal Medicine American Medical Association

(Mis)Treatment of Acute Herpes Zoster

Archives of Internal Medicine , Volume 154 (18) – Sep 26, 1994

(Mis)Treatment of Acute Herpes Zoster

Abstract

Abstract Recent attention has been focused on new antiviral agents for the treatment of herpes zoster both in the medical literature1 and in the lay press (Wall Street Journal. July 12, 1933;B1, 5). Since acyclovir was approved for treatment of herpes zoster in April 1990, we have kept a log at the University of Texas Medical Branch, Galveston, of patients presenting at our clinics who inform us that they were previously treated for shingles by their local physician. Interestingly, only 33...
Loading next page...
 
/lp/american-medical-association/mis-treatment-of-acute-herpes-zoster-x7rR6q6tka
Publisher
American Medical Association
Copyright
Copyright © 1994 American Medical Association. All Rights Reserved.
ISSN
0003-9926
eISSN
1538-3679
DOI
10.1001/archinte.1994.00420180119014
Publisher site
See Article on Publisher Site

Abstract

Abstract Recent attention has been focused on new antiviral agents for the treatment of herpes zoster both in the medical literature1 and in the lay press (Wall Street Journal. July 12, 1933;B1, 5). Since acyclovir was approved for treatment of herpes zoster in April 1990, we have kept a log at the University of Texas Medical Branch, Galveston, of patients presenting at our clinics who inform us that they were previously treated for shingles by their local physician. Interestingly, only 33 (17%) of 197 of these patients had received acyclovir at the recommended dosage of 800 mg orally five times per day for 7 to 10 days. Another 56% of the patients reported being treated with acyclovir at lower oral dosages and/or with topical acyclovir. The remaining 27% of patients were treated with oral antibacterial agents and/or a variety of other non-antiviral drugs. As we actively enroll patients in clinical References 1. Straus SE. Shingles: sorrows, salves, and solutions . JAMA . 1993;269:1836-1839.Crossref

Journal

Archives of Internal MedicineAmerican Medical Association

Published: Sep 26, 1994

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$499/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month